Ziyuanyuan Holdings Group Limited (HKG:8223)
0.4700
-0.0100 (-2.08%)
Apr 24, 2026, 3:55 PM HKT
Ziyuanyuan Holdings Group Revenue
In the year 2025, Ziyuanyuan Holdings Group had annual revenue of 481.64M CNY, down -3.42%. Ziyuanyuan Holdings Group had revenue of 274.53M in the half year ending December 31, 2025, a decrease of -12.08%.
Revenue
481.64M CNY
Revenue Growth
-3.42%
P/S Ratio
0.45
Revenue / Employee
10.95M CNY
Employees
44
Market Cap
242.52M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 481.64M | -17.07M | -3.42% |
| Dec 31, 2024 | 498.71M | 20.13M | 4.21% |
| Dec 31, 2023 | 478.57M | 173.20M | 56.72% |
| Dec 31, 2022 | 305.37M | 196.11M | 179.49% |
| Dec 31, 2021 | 109.26M | 60.48M | 123.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 653.24B |
| Charmacy Pharmaceutical | 4.88B |
| ETHK Labs | 3.14B |
| Sinco Pharmaceuticals Holdings | 2.32B |
| Sipai Health Technology | 2.30B |
| ClouDr Group | 1.81B |
| 160 Health International | 725.41M |
| Wanjia Group Holdings | 163.70M |